Endoscopic Coolsculpting – A Novel Way To Remove Stubborn Fat

Coolsculpting is an affiliate of Allergen Med Systems, a division of Astraware base, which produces and licenses medical devices specifically used for the cryolipodial processes. The company was established in 2021 and raised a whopping $75 million in capital before going public on the market. In late 2021 it was purchased by Allergen in a deal valued at approximately $70 million. The acquisition marks the beginning of a stunning expansion for Coolsculpting. It uses its mechanical engineering expertise to manufacture and design a wide range of medical equipment used in the cryobiology industry, with an emphasis on precision engineering. Visit homepage Melinda Silva, MD Anti-Aging & Wellness-Coolsculpting

There are multiple uses for Coolsculpting, including the manufacturing of customized liposuction trays for liposuction of stubborn fat cells. Another application is the manufacturing and design of endoscope trimming tool covers, specifically for use in the treatment of the abdomen, pelvis and lower back. These Coolsculpting trays help maintain a stable temperature even during long hours of surgery. The trays also help reduce the incidence of leaking and other problems related to incorrect plastic surgery tools. These trays are not merely for cosmetic use but are designed for use in cold climates to promote better circulation.

One can expect Coolsculpting’s innovative approach to endoscopic fat removal to result in minimal side effect to patients. The most common side effect reported in case studies was dehydration or low blood pressure. However, most users have experienced either mild burning sensation or itchiness in the treated area. This usually disappears within a day or two and can be managed by the patient taking medications. In rare cases, patients experience severe side effect such as allergic reactions, increased bruising and swelling in the treated area.